<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_TUDelft_Parts_BasicPart skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:TUDelft/Parts/BasicPart</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="container"><DIV class="row"><DIV class="col-lg-10 col-md-10 col-sm-10 col-xs-10 nowbg"><H1 class="grnbl">Basic Parts</H1><P>
When constructing our BioBricks, we made use of the IDT synthesis offer. This way we were able to generate our required parts in a fast and efficient way. Additionally, we made use of PCR amplification with our constructed expression plasmids as template to construct several BioBricks. All of the parts contain a coding sequence, some of which extended with promoters or introns. The basic parts forming our <A href="http://parts.igem.org/Part:BBa_K2643000" class="grnbl" target="_blank">fusion protein</A><A href="https://2018.igem.org/Team:TUDelft/Composite_Parts" class="grnbl">composite part</A> are documented separately and also exist as separate BioBricks. This is advantageous for those wishing to combine one of our basic parts with a different expression level or compose a different composite part altogether. All BioBricks are submitted with elaborate characterisation so the user may choose the best protein for their project accordingly. Our favourite basic part is dxCas9 <A href="http://parts.igem.org/Part:BBa_K2643001" class="grnbl" target="_blank">BBa_K2643001</A>.
</P><FIGCAPTURE class="grnbl"><B>Table 1.</B> Basic Parts submitted by TU Delft iGEM 2018 team. All BioBricks were constructed by the team members involved in wetlab: Susan Bouwmeester, Kavish Kohabir, Venda Mangkusaputra, Timmy Paez, Lisbeth Schmidtchen and Nicole Bennis</FIGCAPTURE><TABLE><TBODY><TR class="tableheadergrnbl"><TH class="tableheadergrnbl">♥</TH><TH class="tableheadergrnbl">Name</TH><TH class="tableheadergrnbl">Type</TH><TH class="tableheadergrnbl">Description</TH><TH class="tableheadergrnbl">Designer</TH></TR><TR class="tableunevengrnbl"><TD>♥</TD><TD><A href="http://parts.igem.org/Part:BBa_K2643001" target="_blank" class="jnnbl">BBa_K2643001</A></TD><TD>Basic</TD><TD>dxCas9 (HIS Tag)</TD><TD>TU Delft 2018</TD></TR><TR class="tableevengrnbl"><TD>♥</TD><TD><A href="http://parts.igem.org/Part:BBa_K2643002" target="_blank" class="jnnbl">BBa_K2643002</A></TD><TD>Basic</TD><TD>Tn5 Transposase (HIS Tag)</TD><TD>TU Delft 2018</TD></TR><TR class="tableunevengrnbl"><TD><A href="http://parts.igem.org/Part:BBa_K2643003" target="_blank" class="jnnbl">BBa_K2643003</A></TD><TD>Basic</TD><TD>Glycine Helical peptide Linker (GHL)</TD><TD>TU Delft 2018</TD></TR><TR class="tableevengrnbl"><TD>♥</TD><TD><A href="http://parts.igem.org/Part:BBa_K2643004" target="_blank" class="jnnbl">BBa_K2643004</A></TD><TD>Basic</TD><TD>Coding region (CDS) of human erythropoietin (EPO) hormone</TD><TD>TU Delft 2018</TD></TR><TR class="tableunevengrnbl"><TD><A href="http://parts.igem.org/Part:BBa_K2643005" target="_blank" class="jnnbl">BBa_K2643005</A></TD><TD>Basic</TD><TD>Human EPO gene with artificial intron (615 bp)</TD><TD>TU Delft 2018</TD></TR><TR class="tableevengrnbl"><TD><A href="http://parts.igem.org/Part:BBa_K2643006" target="_blank" class="jnnbl">BBa_K2643006</A></TD><TD>Basic</TD><TD>Human EPO gene with artificial intron (135 bp)</TD><TD>TU Delft 2018</TD></TR><TR class="tableunevengrnbl"><TD><A href="http://parts.igem.org/Part:BBa_K2643007" target="_blank" class="jnnbl">BBa_K2643007</A></TD><TD>Basic</TD><TD>Human EPO gene with 2 artificial introns (615 + 135 bp)</TD><TD>TU Delft 2018</TD></TR><TR class="tableevengrnbl"><TD><A href="http://parts.igem.org/Part:BBa_K2643008" target="_blank" class="jnnbl">BBa_K2643008</A></TD><TD>Basic</TD><TD>Human EPO gene with mutation 1 (5 bp)</TD><TD>TU Delft 2018</TD></TR><TR class="tableunevengrnbl"><TD><A href="http://parts.igem.org/Part:BBa_K2643009" target="_blank" class="jnnbl">BBa_K2643009</A></TD><TD>Basic</TD><TD>Human EPO gene with mutation 2 (12 bp)</TD><TD>TU Delft 2018</TD></TR><TR class="tableevengrnbl"><TD><A href="http://parts.igem.org/Part:BBa_K2643010" target="_blank" class="jnnbl">BBa_K2643010</A></TD><TD>Basic</TD><TD>gRNA expression cassette for CRISPR-targeting <I>lacZ</I></TD><TD>TU Delft 2018</TD></TR><TR class="tableunevengrnbl"><TD><A href="http://parts.igem.org/Part:BBa_K2643011" target="_blank" class="jnnbl">BBa_K2643011</A></TD><TD>Basic</TD><TD>Mosaic Ends-flanked Kanamycin cassette and RFP</TD><TD>TU Delft 2018</TD></TR></TBODY></TABLE></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>